Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 2.43% | $4.03M | €435.69B | 61.23% | 76 Outperform | |
| Roche Holding AG | 1.41% | $2.35M | CHF287.79B | 44.65% | 73 Outperform | |
| HSBC Holdings | 1.35% | $2.25M | £224.58B | 50.66% | 80 Outperform | |
| AstraZeneca | 1.30% | $2.16M | £213.91B | 18.62% | 80 Outperform | |
| Novartis AG | 1.27% | $2.11M | CHF225.91B | 22.08% | 80 Outperform | |
| Toyota Motor | 1.21% | $2.01M | ¥48.55T | 27.64% | 80 Outperform | |
| Nestlé SA | 1.12% | $1.86M | CHF197.51B | 17.29% | 71 Outperform | |
| Royal Bank Of Canada | 1.06% | $1.76M | $238.05B | 42.79% | 75 Outperform | |
| Siemens | 1.00% | $1.67M | €188.82B | 17.68% | 74 Outperform | |
| Mitsubishi UFJ Financial Group | 0.99% | $1.64M | ¥32.98T | 41.02% | 76 Outperform |